# How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-related-cancer-risks-in-adolescents-young-adults/ > **Published:** 2026-04-09T13:22:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:37-04:00 > **Clinical Summary:** Explore cannabis-related cancer risks and their potential impact on breast and testicular cancer rates in adolescents and young adults. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CancerResearchSafetyPediatrics Why This Matters Clinicians caring for adolescents and young adults should be aware of potential cannabis-related cancer risks in this population to enable informed counseling about use and to identify patients who may benefit from enhanced screening or surveillance. Understanding whether cannabis accelerates breast and testicular cancer development could shift clinical guidance on substance use counseling for teenagers and young adults at critical developmental stages. This evidence is particularly relevant for oncologists and primary care providers managing AYA patients with these cancers, as [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) history may inform risk stratification and follow-up protocols. Clinical Summary This epidemiological analysis examines the potential association between cannabis use and rising incidence rates of breast and testicular cancers in adolescents and young adults (AYAs), a demographic showing concerning cancer trend acceleration. The research suggests that cannabis exposure during developmentally critical periods of reproductive tissue maturation may increase cancer susceptibility through mechanisms including [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) disruption, inflammatory pathways, and alterations in hormone signaling. Given the increasing prevalence of cannabis use in younger populations and the growing normalization of cannabis products, clinicians should consider obtaining detailed cannabis use history during oncology risk assessment and counseling for adolescent and young adult patients. The findings have particular relevance for primary care physicians advising young patients about [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/), as reproductive cancer risk represents a significant long-term health consequence beyond commonly discussed acute effects. Clinicians should counsel patients and families that cannabis use during adolescence and early adulthood may carry previously underappreciated cancer risks and should incorporate this information into shared decision-making conversations about substance use. Dr. Caplan’s Take “What concerns me most about this data is not that cannabis causes cancer, but that we’re seeing a correlation in young people during a critical window of reproductive and endocrine development, and we have almost no prospective data on how cannabinoids affect hormonally-sensitive tissues in this population. Until we do, I counsel my younger patients that the risk-benefit calculus is simply different for them than it is for a 55-year-old using [cannabis for arthritis](https://cedclinic.com/cannabinoid-treatments-rheumatic-diseases-efficacy-safety/), and that honesty matters more than reassurance.” Clinical Perspective While this research raises important questions about cannabis exposure during critical developmental periods in adolescents and young adults, clinicians should recognize that establishing causality between cannabis use and cancer incidence requires careful interpretation, as the study may reflect correlation, reporting bias, or confounding factors such as shared genetic susceptibility or concurrent exposures. Current epidemiological evidence on cannabis and hormone-sensitive cancers remains mixed and limited, particularly regarding dose, frequency, duration, and timing of use relative to cancer development. Nevertheless, the biological plausibility of cannabinoid effects on endocrine signaling warrants attention in clinical contexts where young patients report regular cannabis use. Healthcare providers caring for adolescents and young adults should incorporate cannabis use history into comprehensive risk assessment discussions, counseling patients—particularly those with family histories of breast or testicular cancer—about potential risks while acknowledging that high-quality prospective evidence is still emerging. Until more definitive evidence accrues, 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+How+Cannabis+Use+May+Be+Accelerating+Breast+and+Testicular+Cancer+Rates+in+AYAs+%40drcaplan&url=https%3A%2F%2Fascopost.com%2Fnews%2Fapril-2026%2Fhow-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fascopost.com%2Fnews%2Fapril-2026%2Fhow-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+How+Cannabis+Use+May+Be+Accelerating+Breast+and+Testicular+Cancer+Rates+in+AYAs+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fascopost.com%2Fnews%2Fapril-2026%2Fhow-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://ascopost.com/news/april-2026/how-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas/](https://ascopost.com/news/april-2026/how-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study highlights stroke risk linked to recreational drugs, including among young users](https://cedclinic.com/cannabis-stroke-risk-young-users-study-highlights/) This study explores the risks associated with recreational drug use, including cannabis, among young populations. [Read Study](https://cedclinic.com/cannabis-stroke-risk-young-users-study-highlights/) [New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks](https://cedclinic.com/cannabis-related-psychiatric-risks-adolescents/) Discover how age influences psychiatric risks related to cannabis use, relevant to adolescent and young adult health. [Explore Research](https://cedclinic.com/cannabis-related-psychiatric-risks-adolescents/) Teenage Cannabis Use Linked to 52% Higher Schizophrenia Risk – Neuroscience News This article discusses the increased psychiatric risks associated with teenage cannabis use, highlighting important clinical considerations. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).